11/15/2024
3:31 PM | Evoke Pharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2024
8:19 AM | Altium Capital Management LP (Filed by)
Evoke Pharma (Subject)
| Form SC 13G/A | |
10/29/2024
6:47 PM | Evoke Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
10/28/2024
7:10 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
4:07 PM | Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
4:09 PM | Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
8:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/17/2024
3:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:08 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:11 PM | Evoke Pharma (Filer)
| Form 424B3 | |
09/20/2024
6:28 PM | Evoke Pharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13D | |
09/08/2024
11:15 PM | Evoke Pharma (Filer)
| Form EFFECT | |
08/29/2024
3:16 PM | Evoke Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/21/2024
11:15 PM | Evoke Pharma (Filer)
| Form EFFECT | |
08/16/2024
6:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:15 AM | Evoke Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
7:20 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:11 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:48 PM | D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:01 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
7:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
5:09 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:53 PM | Brady Todd C (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:58 PM | Evoke Pharma (Filer)
| Form ARS/A | |
05/14/2024
3:20 PM | Evoke Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:05 PM | Evoke Pharma (Filer)
| Form 10-K/A | |
05/14/2024
3:00 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
2:34 PM | Evoke Pharma (Filer)
| Form DEF 14A | |
04/10/2024
2:35 PM | Evoke Pharma (Filer)
| Form DEFA14A | |
04/10/2024
2:36 PM | Evoke Pharma (Filer)
| Form ARS | |
03/25/2024
3:55 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:56 PM | Evoke Pharma (Filer)
| Form 424B3 | |
03/21/2024
3:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
12:32 PM | Evoke Pharma (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
03/11/2024
5:39 PM | Bleichroeder LP (Filed by)
Evoke Pharma (Subject)
| Form SC 13G | |
02/23/2024
3:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
3:38 PM | Altium Capital Management LP (Filed by)
Evoke Pharma (Subject)
| Form SC 13G | |
02/13/2024
5:34 AM | Evoke Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/09/2024
4:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
02/08/2024
11:15 PM | Evoke Pharma (Filer)
| Form EFFECT | |
02/08/2024
5:50 AM | Evoke Pharma (Filer)
| Form S-1/A | |
01/10/2024
8:38 PM | Evoke Pharma (Filer)
| Form S-1/A | |
12/19/2023
7:30 AM | Evoke Pharma (Filer)
| Form S-1/A | |
12/15/2023
3:30 PM | Evoke Pharma (Filer)
| Form S-1/A | |
11/29/2023
8:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
3:30 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
